推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

ChemMedChem 期刊收藏夹

欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此反馈;如有合作推广需求,请点此洽谈

按期刊名首写字母查看 CHEMMEDCHEM最新评论:10天左右从编辑转到审稿人,7天内发来小修意见,回复完意见第三天就暂时接受,1个月不到从提交到接受。就是今年降区了很难受 (2023-02-19)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
SCI论文AI润色+人工QC服务
同行专家帮助选刊
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


ChemMedChem期刊基本信息Hello,您是该期刊的第79260位访客


基本信息 登录收藏
期刊名字ChemMedChemChemMedChem

CHEMMEDCHEM
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.7
53人评分
我要评分

声誉
7.6

影响力
5.4

速度
9.6

期刊ISSN1860-7179
蝌蝌APP,让您与同行交流更轻松
立即下载
E-ISSN1860-7187
2024-2025最新影响因子
(数据来源于搜索引擎)
3.4 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:3.338
2024-2025自引率5.90%点击查看自引率趋势图
五年影响因子3.4
JCI期刊引文指标 0.83
h-index 92
CiteScore
2025年最新版
CiteScoreSJRSNIPCiteScore排名
6.700.7170.797
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:General Pharmacology, Toxicology and Pharmaceutics
Q18 / 77
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Organic Chemistry
Q152 / 212
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q289 / 321
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q250 / 156
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Biochemistry
Q2156 / 441
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q267 / 177

期刊简介
Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.

ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.

Contents
ChemMedChem publishes an attractive mixture of:

Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews.
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/CMDC
期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ChemMedChem的语言要求,还能让ChemMedChem编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ChemMedChem编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式WILEY-V C H VERLAG GMBH, PO BOX 10 11 61, WEINHEIM, GERMANY, D-69451
出版商John Wiley and Sons Ltd
涉及的研究方向医学-药学
出版国家或地区GERMANY
出版语言English
出版周期Monthly
出版年份2006
年文章数 330点击查看年文章数趋势图
Gold OA文章占比35.05%
研究类文章占比:
文章 ÷(文章 + 综述)
77.88%
WOS期刊SCI分区
2024-2025年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:CHEMISTRY, MEDICINALSCIEQ236/72
学科:PHARMACOLOGY & PHARMACYSCIEQ2113/352
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:CHEMISTRY, MEDICINALSCIEQ232/72
学科:PHARMACOLOGY & PHARMACYSCIEQ2110/353
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2025年3月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区4区4区
CHEMISTRY, MEDICINAL
药物化学
3区3区3区
PHARMACOLOGY & PHARMACY
药学
3区4区4区
中国科学院SCI期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区2区
CHEMISTRY, MEDICINAL
药物化学
1区4区4区
PHARMACOLOGY & PHARMACY
药学
4区3区4区
中国科学院SCI期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区4区2区
CHEMISTRY, MEDICINAL
药物化学
1区2区4区
PHARMACOLOGY & PHARMACY
药学
1区2区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1860-7179%5BISSN%5D
平均审稿速度网友分享经验:
平均1.0个月
平均录用比例网友分享经验:
约75%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在ChemMedChem顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 ChemMedChem期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 ChemMedChem中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
ChemMedChem上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    DRUG RESISTANCE UPDATES10023.20
    TRENDS IN PHARMACOLOGICAL SCIENCES20125.70
    ADVANCED DRUG DELIVERY REVIEWS27836.00
    PHARMACOLOGICAL REVIEWS21034.00
    PHARMACOLOGY & THERAPEUTICS18026.20
    MEDICINAL RESEARCH REVIEWS11929.50
    PHARMACOLOGICAL RESEARCH11818.60
    PHYTOMEDICINE10511.60
    DRUG DELIVERY5216.40
    BRITISH JOURNAL OF PHARMACOLOGY19014.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE743579
    BIOMATERIALS615814
    BIOMEDICINE & PHARMACOTHERAPY609019
    Frontiers in Pharmacology575766
    COMPUTERS IN BIOLOGY AND MEDICINE572019
    JOURNAL OF ETHNOPHARMACOLOGY567249
    Frontiers in Immunology563544
    Frontiers in Oncology504467
    COLLOIDS AND SURFACES B-BIOINTERFACES471844
    PHYTOMEDICINE469093
  •  

    ChemMedChem ChemMedChem
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Signaling Pathways and Promising Small-Molecule Therapeutic Agents for Ischemic Stroke

    Author: Das, Debasis; Wu, Yimeng; Hong, Jian
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202400975
        PubMed      DOI
    2.Significant Tumor Inhibition of Trimethyl-152-[L-aspartyl]pheophorbide a in Tumor Photodynamic Therapy≠

    Author: Benic, Anita; Kussayeva, Akmaral; Antol, Ivana; Vazdar, Mario; Brkljaca, Zlatko; Chen, Dan-Ye; Yan, Yi-Jia; Gao, Ying-Hua; Chen, Zhi-Long; Margetic, Davor
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202500087
        PubMed      DOI
    3.Adipocyte-Targeted Nanotechnology and Cell-Based Therapy for Obesity Treatment (vol 20, e202400611, 2025)

    Author: Wu, Yue; Deng, Siqi; Wei, Siyu; Wei, Wenqi; He, Yunxiang; Guo, Junling
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202500240
        DOI
    4.Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability

    Author: Gu, Yiming; Yu, Wei; Li, Xiang; Fan, Yingjie; Liu, Yanan; Tummatorn, Jumreang; Jiang, Siyu; Yang, Jingyue
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202400979
        PubMed      DOI
    5.Hybrid Molecules as Efficient Drugs against Multidrug-Resistant Malaria Parasites

    Author: Robert, Anne; Paloque, Lucie; Augereau, Jean-Michel; Nardella, Flore; Nguyen, Michel; Meunier, Bernard; Benoit-Vical, Francoise
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202500086
        PubMed      DOI
    6.Membrane Proteins in Nanodiscs: Methods and Applications

    Author: Guo, Jiaxu; Hou, Qinghan; Tan, Yulin; Fu, Ruoheng; Huang, Xuanwei; Cao, Chan
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202400775
        PubMed      DOI
    7.Advances in Lipid Nanoparticle-Based Disease Treatment

    Author: Zhou, Yujie; Ge, Qiqi; Wang, Xin; Wang, Yuhui; Sun, Qianqian; Wang, Jianhao; Yang, Tie; Wang, Cheng
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202400938
        PubMed      DOI
    8.Small-Molecule Fluorescent Probes for Butyrylcholinesterase

    Author: Lin, Zibo; Liao, Yuanyuan; Tian, Donglei; Liao, Junyu; Chen, Qiong; Yin, Jun
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202400875
        PubMed      DOI
    9.2-Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors

    Author: Ma, Zheng; Cui, Ge; Dou, Lijie; Chen, Fangfang; Xie, Hexin
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202400901
        PubMed      DOI
    10.Design, Synthesis, and Biological Assessment of Novel Aminobenzidazole Agonists Targeting the Stimulator of Interferon Genes (STING) Receptor Signaling Pathway for Oncology Immunotherapy

    Author: Fan, Yiqing; Zeng, Zeqi; Mo, Jiaxian; Wang, Zike; Jiang, Hongyu; Liu, Juanjuan; Qian, Hai; Shi, Wei
    Journal: CHEMMEDCHEM. 2025; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202400695
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    同分区等级的其他期刊名称 h-index CiteScore
    Corrosion Communications013.60
    Water Cycle09.60
    Journal of Road Engineering010.30
    Ukrainian Journal of Physical Optics1412.30
    Integrated Environmental Assessment and Management486.90
    Progress of Theoretical and Experimental Physics3110.40
    Journal of Obesity & Metabolic Syndrome011.10
    HARVARD BUSINESS REVIEW01.80
    PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF THE PACIFIC1367.90
    Pulse00.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共23


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室